Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tazarotene Gel vs Microneedling for Atrophic Post-Acne Scars
NCT05573425Phase 3Completed
- Sponsor
- Jinnah Postgraduate Medical Centre
- Start
- Aug 2020
- Primary completion
- Feb 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tazarotene in atrophic acne scars (2 arms), sponsored by Jinnah Postgraduate Medical Centre. Primary endpoint: Change in morphology of Acne Scars at 6 months. Started Aug 2020; status: completed.
02
Drugs
tazarotene
03
Conditions
atrophic acne scars
Beyond the preview
Go deeper on NCT05573425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05573425.